(redirected from Mutation rate)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.

MUTATION, French law. This term is synonymous with change, and is particularly applied to designate the change which takes place in the property of a thing in its transmission from one person to another; permutation therefore happens when, the owner of the thing sells, exchanges or gives it. It is nearly synonymous with transfer. (q.v.) Merl. Repert. h.t.

A Law Dictionary, Adapted to the Constitution and Laws of the United States. By John Bouvier. Published 1856.
References in periodicals archive ?
In case of average mutations per individual, favorable mutation rate per offspring is considered 0.01.
Southern Asia had a significantly higher exon 21 L858R mutation rate compared with northern Asia.
The observed locus specific mutation rate ranged between 0 for DYS19, DYS389I, DYS390, DYS391, DYS392, DYS393, DYS437, DYS348, DYS439, DYS448, DYS456, DYS458, DYS635, and Y-GATA-H4 loci and 1.765 x [10.sup.-3] (1.43 x [10.sup.-4] - 4.243 x [10.sup.-3]) for DYS385a locus at 95% CI [9].
The mutation rate we found in Turkish patients (16.7%) is slightly higher than that reported in earlier studies on Caucasians.
Otherwise, the mutation rate was increased to allow chromosomes to change towards a better population.
A high mutation rate was observed in known drug-resistance markers such as pvcrt-o K10 AAG insert (66.6%, 14/21), pvdhps (100.0%, 20/20), pvdhfr (100.0%, 21/21), and pvmdr1 (100.0%, 21/21) (Table).
In the IGA-negative group, the -611 (G/A) mutation rate was 88.3%, and the -56 (T/C) mutation rate was 84.5% (-611 (G/A), -56 (T/C): 79 cases; -611 (G/A), -56 (T/T): 14 cases; -611 (G/G), -56 (T/C): 9 cases; and -611 (G/G), -56 (T/T): 3 cases).
The main parameters considered in this study are mutation rate, size of the population, and number of generations.
Therefore, the lower mutation rate presented in this study may be due to the regional difference or the smaller sample size.
Roughly the same mutation rate was found in stem cells from organs with different cancer incidence, suggesting that accumulation of "bad luck" DNA errors over time doesn't explain the difference seen in cancer incidence, at least for some cancers.
(13) found an 8.0% prevalence of total and primary mutations among untreated CHB patients in China, and that Southern China had a little higher pooled total mutation rate of 8.22% than Northern China 7.55%.